[1] Xu XY, Subbarao K, Cox NJ, et al. Genetic characterization of the pathogenic influenza A/goose/Guangdong/1/96(H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virol, 1999; 261, 15−9. doi:  10.1006/viro.1999.9820
[2] Duan L, Bahl J, Smith GJD, et al. The development and genetic diversity of H5N1 influenza virus in China, 1996-2006. Virol, 2008; 380, 243−54. doi:  10.1016/j.virol.2008.07.038
[3] Smith GJD, Donis RO, World Health Organization/World Organisation for Animal Health/Food and Agriculture Organization (WHO/OIE/FAO) H5 Evolution Working Group. Nomenclature updates resulting from the evolution of avian influenza A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013-2014. Influenza Other Respir Viruses, 2015; 9, 271−6. doi:  10.1111/irv.12324
[4] Pasick J, Berhane Y, Joseph T, et al. Reassortant highly pathogenic influenza A H5N2 virus containing gene segments related to Eurasian H5N8 in British Columbia, Canada, 2014. Sci Rep, 2015; 5, 9484. doi:  10.1038/srep09484
[5] Su S, Bi YH, Wong G, et al. Epidemiology, evolution, and recent outbreaks of avian influenza virus in China. J Virol, 2015; 89, 8671−6. doi:  10.1128/JVI.01034-15
[6] Lee DH, Torchetti MK, Winker K, et al. Intercontinental spread of Asian-origin H5N8 to north america through beringia by migratory birds. J Virol, 2015; 89, 6521−4. doi:  10.1128/JVI.00728-15
[7] World Health Organization. Monthly risk assessment summary-influenza at the human-animal interface. 27 September 2019. https://www.who.int/influenza/human_animal_interface/Influenza_Summary_IRA_HA_interface. [2020-01-22]
[8] World Health Organization. Cumulative number of confirmed human cases of avian Influenza A(H5N1) reported to WHO, 2003-2019. https://www.who.int/influenza/human_animal_interface/2019_11_25_tableH5N1.pdf. [2019-12-21]
[9] Pan M, Gao RB, Lv Q, et al. Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings. J Infect, 2016; 72, 52−9. doi:  10.1016/j.jinf.2015.06.009
[10] World Health Organization. Monthly risk assessment summary-influenza at the human-animal interface. 20 January 2020. https://www.who.int/influenza/human_animal_interface/HAI_Risk_Assessment/en/. [2020-01-22]
[11] Lee DH, Bahl J, Torchetti MK, et al. Highly pathogenic avian influenza viruses and generation of novel reassortants, United States, 2014-2015. Emerg Infect Dis, 2016; 22, 1283−5. doi:  10.3201/eid2207.160048
[12] Si YJ, Lee IW, Kim EH, et al. Genetic characterisation of novel, highly pathogenic avian influenza (HPAI) H5N6 viruses isolated in birds, South Korea, November 2016. Euro Surveill, 2017; 22, 30434. doi:  10.2807/1560-7917.ES.2017.22.1.30434
[13] Butler J, Stewart CR, Layton DS, et al. Novel reassortant H5N6 influenza A virus from the Lao People’s Democratic Republic is highly pathogenic in chickens. PLoS One, 2016; 11, e0162375. doi:  10.1371/journal.pone.0162375
[14] Chu DH, Okamatsu M, Matsuno K, et al. Genetic and antigenic characterization of H5, H6 and H9 avian influenza viruses circulating in live bird markets with intervention in the center part of Vietnam. Vet Microbiol, 2016; 192, 194−203. doi:  10.1016/j.vetmic.2016.07.016
[15] Takemae N, Tsunekuni R, Sharshov K, et al. Five distinct reassortants of H5N6 highly pathogenic avian influenza A viruses affected Japan during the winter of 2016-2017. Virology, 2017; 512, 8−20. doi:  10.1016/j.virol.2017.08.035
[16] World Health Organization. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness. 29 September 2016. https://www.who.int/influenza/vaccines/virus/201609_zoonotic_vaccinevirusupdate.pdf. [2017-09-21]
[17] World Health Organization. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness. 22 February 2018. https://www.who.int/influenza/vaccines/virus/201802_zoonotic_vaccinevirusupdate.pdf. [2018-09-02]
[18] Skowronski DM, Janjua NZ, De Serres G, et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One, 2014; 9, e92153. doi:  10.1371/journal.pone.0092153
[19] Liu LQ, Lu J, Li Z, et al. 220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development. Hum Vaccin Immunother, 2018; 14, 532−9. doi:  10.1080/21645515.2017.1419109
[20] Zost SJ, Parkhouse K, Gumina ME, et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc Natl Acad Sci USA, 2017; 114, 12578−83. doi:  10.1073/pnas.1712377114
[21] Nicolson C, Major D, Wood JM, et al. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine, 2005; 23, 2943−52. doi:  10.1016/j.vaccine.2004.08.054
[22] Zhang H, Liu MB, Zeng XX, et al. Identification of a novel reassortant A (H9N6) virus in live poultry markets in Poyang Lake region, China. Arch Virol, 2017; 162, 3681−90. doi:  10.1007/s00705-017-3507-x
[23] World Organization for Animal Health (OIE). Avian influenza (infection with avian influenza viruses). In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. OIE. 2016, 1-23.
[24] World Health Organization. Guidelines for the safe development and production of vaccines to human pandemic influenza viruses and influenza viruses with pandemic potential, 2019. https://www.who.int/biologicals/expert_committee/Annex_3_WHO_TRS_1016_web3.pdf. [2019-05-10]
[25] WHO Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza. WHO Press. 2011.
[26] Plant EP, Liu TM, Xie H, et al. Mutations to A/Puerto Rico/8/34 PB1 gene improves seasonal reassortant influenza A virus growth kinetics. Vaccine, 2012; 31, 207−12. doi:  10.1016/j.vaccine.2012.10.060
[27] Wen F, Li L, Zhao N, et al. A Y161F hemagglutinin substitution increases thermostability and improves yields of 2009 H1N1 influenza A virus in cells. J Virol, 2018; 92, e01621−17.
[28] Belser JA, Katz JM, Tumpey TM. The ferret as a model organism to study influenza A virus infection. Dis Model Mech, 2011; 4, 575−9. doi:  10.1242/dmm.007823
[29] Sun HL, Pu J, Wei YD, et al. Highly pathogenic avian influenza H5N6 viruses exhibit enhanced affinity for human type sialic acid receptor and in-contact transmission in model ferrets. J Virol, 2016; 90, 6235−43. doi:  10.1128/JVI.00127-16
[30] Sutton TC. The pandemic threat of emerging H5 and H7 avian influenza viruses. Viruses, 2018; 10, 461. doi:  10.3390/v10090461
[31] Antigua KJC, Choi WS, Baek YH, et al. The emergence and decennary distribution of clade 2.3.4.4 HPAI H5Nx. Microorganisms, 2019; 7, 156. doi:  10.3390/microorganisms7060156
[32] World Health Organization. Antigenic and genetic characteristics of zoonotic influenza A viruses and development of candidate vaccine viruses for pandemic preparedness. 30 September 2019. https://www.who.int/influenza/vaccines/virus/201909_zoonotic_vaccinevirusupdate.pdf. [2020-01-20]
[33] Robertson JS, Nicolson C, Harvey R, et al. The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine, 2011; 29, 1836−43. doi:  10.1016/j.vaccine.2010.12.044
[34] Ridenour C, Johnson A, Winne E, et al. Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs. Influenza Other Respir Viruses, 2015; 9, 263−70. doi:  10.1111/irv.12322
[35] Kwon HI, Kim EH, Kim YI, et al. Comparison of the pathogenic potential of highly pathogenic avian influenza (HPAI) H5N6, and H5N8 viruses isolated in South Korea during the 2016-2017 winter season. Emerg Microbes Infect, 2018; 7, 29.
[36] Herfst S, Mok CKP, van den Brand JMA, et al. Human clade 2.3.4.4 A/H5N6 influenza virus lacks mammalian adaptation markers and does not transmit via the airborne route between ferrets. mSphere, 2018; 3, e00405−17.
[37] Belser JA, Johnson A, Pulit-Penaloza JA, et al. Pathogenicity testing of influenza candidate vaccine viruses in the ferret model. Virol, 2017; 511, 135−41. doi:  10.1016/j.virol.2017.08.024